joint tissues of AIA rat were restored by BAPTA/AM. Knockdown of calmodulin, calpains, and calcineurin in RAFLS confirmed the role of Ca 2+ in celastrol-regulated gene expression.
Conclusion and Implications:
Celastrol triggered Ca 2+ signalling to induce autophagic cell death in RASFs/RAFLS and ameliorated arthritis in AIA rats mediated by calcium-dependent/-binding proteins facilitating the exploitation of anti-arthritic drugs based on manipulation of Ca 2+ signalling.
| INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune condition exhibiting polyarthritis and multiple organ disorders (Tsujimura, Saito, Nawata, Nakayamada, & Tanaka, 2008) . A variety of cell populations such as lymphocytes, macrophages, and synovial fibroblasts (SLFs) are critically involved in the pathogenesis of RA. Rheumatoid arthritis fibroblast-like synoviocytes (RAFLS) and their primary form, rheumatoid arthritis synovial fibroblasts (RASFs) derived from patient SLFs, are considered key cellular participants in arthritic joints. RASFs in diseased articular tissues over-proliferate and they provide a barrier that hinders the delivery of anti-arthritic agents to the inflamed sites (Bartok & Firestein, 2010) . The invasive capacity of RASFs also worsens disease progression by aggravating RA joint erosion via mechanical destruction of normal synovial tissues, neighbouring or distal to the inflamed site (Tolboom et al., 2005) . These factors, together with the multidrug-and apoptosis-resistant properties of RASFs (Fang et al., 2013; Igarashi, Hirano, Yahagi, Saika, & Ishihara, 2014; Kim et al., 2011; Maillefert et al., 1996) , lead to refractoriness in RA and support RASFs as a promising pharmacological target for the treatment of RA.
Ca 2+ plays an important role in autoimmunity and inherited immunological dysregulation. In systemic lupus erythematosus, the pro-inflammatory cytokine expression of autoreactive T-and B-lymphocytes upon autoantigens stimulation is manipulated by Ca 2+ signalling (Tsokos, 2011) . During RA progression, autoreactive T-lymphocytes respond to autoantigens through a molecular mechanism similar to that in systemic lupus erythematosus, suggesting the involvement of Ca 2+ signalling in RA (Sakaguchi et al., 2003) . Our recent PCR screen for in vitro treatments in RASFs (Dias et al., 2018) (Berridge, 2012; Clapham, 2007) . The sarcoplasmic/endoplasmic reticulum (SR/ER) Ca2+-ATPase (SERCA) is the most extensively studied Ca 2+ transporter located in the SR/ER membrane (Stammers et al., 2015) . Recently, SERCA inhibition has been identified as a novel therapeutic strategy for tumourigenesis by triggering cytotoxicity in cancer cells (Denmeade & Isaacs, 2005; Michelangeli & East, 2011) . Suppression of SERCA can severely disrupt Ca 2+ homeostasis to induce the ER stress response, thereby causing mitochondrial damage through Ca 2+ overloading and caspase activation, leading to apoptosis and autophagic cell death (Wong et al., 2013) .
Moreover, SERCA inhibitors can induce autophagic cell death in both apoptosis-and multidrug-resistant cancer cells (Janssen et al., 2009 ).
For instance, the SERCA inhibitor thapsigargin induces autophagyrelated cell death in RASFs via ER stress activation (Kato, Ospelt, Gay, Gay, & Klein, 2014) . By manipulating Ca 2+ signalling to induce autophagic cell death, such findings have suggested the potential use of SERCA inhibitors in RASFs that are resistant to apoptosis.
Tripterygium wilfordii Hook F (TwHF), a Chinese medicinal plant, is an effective medication for RA (Tao & Lipsky, 2000; Jiang et al., 2015; Ma, Zhou, Fan, & Sun, 2016) . A recent clinical investigation revealed that TwHF-based remedies produced better therapeutic outcomes than disease-modifying antirheumatic drugs alone in controlling symptoms of active RA . Another randomized trial also demonstrated that TwHF is more effective than the first-line RA drug sulfasalazine (Goldbach-Mansky et al., 2009) . Additionally, RA patients who failed to respond to conventional therapy were sensitive and showed good tolerance, to multiple therapeutic doses of TwHF (Tao, Younger, Fan, Wang, & Lipsky, 2002) . Celastrol, a triterpene isolated from TwHF, suppressed autoimmune arthritis and reduce bone damage by modulating osteo-immune crosstalk (Nanjundaiah et al., 2012) . Moreover, celastrol inhibited IL-17A-and LPS-stimulated
What is already known
• Celastrol exhibits anti-arthritic effects by targeting Tregs, Th17 cells, and inhibiting NF-κB signalling.
What this study adds
• Celastrol inhibits SERCA to induce autophagy-dependent cytotoxicity in RASFs/RAFLS and represses arthritis in vivo.
• Block of calcium signalling attenuates the in vitro and in vivo effectiveness of celastrol.
What is the clinical significance
• Manipulation of Ca 2+ signalling may represent an alternative approach to the treatment of RA.
migration of RAFLS through the suppression of NF-κB-mediated MMP-9 expression Li et al., 2013) . Celastrol also suppresses arthritis in adjuvant-induced arthritis (AIA) rats by altering the balance between pathogenic and regulatory T cells in the inflamed joints (Astry et al., 2015) . Such beneficial effects have been related to the repression of Th17 cell polarization, associated with the IL-1β signalling pathway (Cascao et al., 2012; Han et al., 2015) . Although celastrol exhibits anti-inflammatory effects by suppressing cell proliferation, invasion, and bone resorption in the treatment of RA (Cascao, Fonseca, & Moita, 2017) , mechanistic studies regarding the Ca
2+
-mobilizing effect of celastrol on RA treatment are scarce. Given that celastrol is able to down-regulate a panel of inflammatory-and autoimmunity-associated genes by mobilizing Ca 2+ in RASFs (Dias et al., 2018) , the current study aimed to examine whether celastrol is able to inhibit SERCA and activate Ca 2+ signalling pathways to mitigate RA, in the well-established experimental AIA model in rats (Astry et al., 2015) , which may provide a new strategy for treating RA via activation of Ca 2+ signalling. (Arnett et al., 1988) . Synovial strips were cut into pieces and cultured in DMEM containing 20% FBS in 25-cm 2 culture flask. Medium was changed every 3 days, and the synovial tissues were collected from the cultured medium after 2 weeks. RASFs were trypsinized and diluted with DMEM containing 20% FBS before subculturing into other flasks. Cells were maintained at 37°C in a humidified incubator supplied with 5% of CO 2 . The purification of RASFs was evaluated by staining for CD90. Cultured
RASFs from passages 5-7 were employed for experimental studies. 
| Endogenous autophagy detection

| Cytotoxicity assays
Cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; 5.0 mg·ml 
| Computational docking
The co-crystal structure of SERCA complexed with thapsigargin was retrieved from the Protein Data Bank (PDB). To prepare the protein for docking, Autodock Tools-1.5.6rc3 was used to remove crystallographic water molecules and to repair missing atoms. The output files after preparation was in PDBQT format. The ligands to be docked were drawn using ChemDraw software and converted into 3D structures using Open Babel. All 3D structures were saved in PDBQT format.
The docking grid box was created and defined by the thapsigargin binding site on SERCA. Celastrol was docked on the selected sites of SERCA using Autodock 4. At each grid point, the energy of a particular ligand configuration was predicted. Docking parameters were set to 250 runs and 2,500,000 energy evaluations for each cycle using the Lamarckian Algorithm. The binding energies and the number of conformations in each cluster were attained from the docking log files (dlg).
2.9 | Measurement of SERCA activity Ca 2+ ATPase (SERCA1A) was extracted and purified from hind leg muscle of female rabbits. The effect of celastrol on Ca 2+ ATPase activity was then determined using the enzyme-coupled method utilizing LDH and pyruvate kinase as previously described (Michelangeli, Colyer, East, & Lee, 1990) . The SERCA inhibitory raw data were fitted to the allosteric concentration-effect equation using Figure P 
| Dual luciferase assay
Briefly, RAFLS were co-transfected with Renilla and one of the luciferase reporter plasmid of ATF6, CHOP, GRP-78, and GRP94 respectively. The next day, cells were treated with indicated concentrations of celastrol and thapsigargin for 24 hr. Cells then harvested with 100 μl of passive lysis buffer before luminescence measurements.
According to the protocol of the dual luciferase reporter assay system (Promega Corp., E1910), 100 μl of the firefly luciferase reagent (LARII) was first added to each test sample, followed by addition of 100 μl of the Renilla luciferase reagent and firefly quenching (Stop & Glo) . The data were represented as the ratio of firefly to Renilla luciferase activity (Fluc/Rluc) from five independent experiments.
2.13 | AIA in rats and treatment At the end of the treatment period, the rats were killed (cervical dislocation during pentobarbital anaesthesia) and the left hind paw was amputated and fixed in 4% PFA, then scanned using in vivo microCT scanner (SkyScan 1176, Bruker, Belgium). The following scanning parameters were used to obtain high-quality images of the joint:
35-μm resolution, 85 kV, 385 μA, 65-ms exposure time, 0.7°rotation step in 360°, and a 1-mm Al filter. The images were reconstructed using NRecon software (Bruker-micro CT, Belgium).
MicroCT score was obtained from five disease-related indices of the microCT analysis for calcaneus (bone mineral density, bone volume fraction, cortical mineral density, trabecular number, and total porosity). MicroCT score was calculated using the formula as follows:
(Acquired value -minimum value)/(maximum value -minimum value) or 1 − (Acquired value -minimum value)/(maximum value -minimum value). The final microCT score is equally averaged from these five indices of disease.
| Immunofluorescent staining of rat synovial tissues
Synovial tissues from all treatment groups were fixed and embedded in paraffin for microtome sectioning and immunofluorescence staining.
After deparaffinization, the tissue sections (5μm thick) were subjected to antigen retrieval (EnVision™ FLEX Target 2.15 | siRNA transfection, RNA extraction, and cDNA synthesis
RASFs were transfected with a mixture of siRNAs using Lipofectamine® 3000 (Invitrogen) according to the manufacturer's protocol.
To maximize the knockdown efficiency for the calcium binding protein (calmodulin, calpains, and calcineurin), the siRNA of these gene isoforms were mixed together before the transfection: siRNA CALM1 + CALM2 + CALM3 for calmodulin, siRNA CAPN1 + CAPN2
for calpains, and siRNA PPP3CA + PPP3CB + PPP3CC for calcineurin.
All siRNA were purchased from Qiagen (Cambridge, USA).
RNA was extracted from the (AIA) animal joint tissues or immortalized RASFs using FavorPrep™ Blood/Cultured Cell Total RNA Purification Mini Kit (Favorgen Biotech Corp.). RNA concentration was determined using the NanoDrop 2000c Spectrophotometer (Thermo Scientific) and 1 μg of total RNA was used to synthesize the corresponding cDNA using the Transcriptor Universal cDNA
Master mix (Roche, USA).
| Real-time quantitative PCR
Quantitative PCR was performed using cDNA prepared from 1 μg of 
| Data and statistical analysis
The data and statistical analysis comply with the recommendations of the British Journal of Pharmacology on experimental design and analysis in pharmacology (Curtis et al., 2018 
| Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMA-COLOGY (Harding et al., 2018) , and are permanently archived in the S186 of Concise Guide to PHARMACOLOGY 2017/18 (Alexander, Christopoulos et al., 2017; Alexander, Fabbro et al., 2017a,b; Alexander, Striessnig et al., 2017) . 
| Calcium chelator BAPTA/AM abolishes celastrol-induced autophagic cell death in RASFs/RAFLS and apoptosis-resistant fibroblasts
The synovial environment in RA patients favours the survival of FLS and prevents their removal by apoptosis and this resistance of FLS to apoptosis has been considered as a major therapeutic challenge (Kim et al., 2011) . Thus, induction of autophagic cell death might serve as an alternative way of eliminating apoptosis-resistant RASFs/RAFLS in RA (Bartok & Firestein, 2010; Turner & Filer, 2015) . Hence, we further validated whether block of Ca 2+ release affects celastrol-induced autophagic cell death in RASFs/RAFLS. Of note, the calcium chelator BAPTA/AM suppressed celastrol-induced endogenous autophagic LC3-II puncta formation in RAFLS (Figure 4a ) and inhibited LC3-II protein conversion in RASFs (Figure 4b) . Concomitantly, annexin V-PI staining showed that both BAPTA/AM and the autophagy inhibitor, wortmannin, reduced celastrol-mediated autophagic cell death (Figure 4c ). These findings suggest that mobilization of Ca 2+ is necessary for celastrol to induce autophagy and autophagic cell death in SLFs. Furthermore, we mimicked the apoptosis-resistant phenotype of RAFLS using apoptosis-resistant fibroblasts, for example, Bax-Bak double-knockout (DKO) MEFs. Interestingly, while the resistant factor of DKO fibroblasts was 1.77 to >14 times more resistant to cell death by the anti-inflammatory agents, leflunomide, tacrolimus, baricitinib, sulfasalazine, and hydroxychloroquine, colchicine, celastrol, and MTX showed little difference in cell death sensitivity in both BaxBak wild-type and DKO fibroblasts ( Figure 5a ). As expected, celastrol was able to induce autophagic puncta formation and autophagic cell death in these apoptosis-resistant fibroblasts, whereas coadministration of BAPTA/AM substantially blocked the celastrolinduced autophagic effects and cell death (Figure 5b ,c). All these findings supported the view that celastrol eliminated SLFs and apoptosis-resistant fibroblasts through calcium-induced autophagic cell death.
| Celastrol-mediated Ca 2+ release induces energy loss and ER stress activation in RAFLS
Abnormal cytosolic Ca 2+ levels can disrupt calcium homeostasis and activate the ER stress response in cells, which further induces the release and overload of Ca 2+ in mitochondria, leading to cytochrome c release and mitochondrial membrane potential loss (Denmeade & Isaacs, 2005) . By LC-MS/MS analysis, we found that the amounts of ATP, ADP, and AMP metabolites in the mitochondria was decreased in the celastrol-treated RAFLS (Figure 5d ), suggesting mitochondrial damage in RAFLS which can be caused by the perturbation of calcium homeostasis (Todd, Lee, & Glimcher, 2008) . As disruption of calcium homeostasis can also lead to activation of the ER stress response as well as apoptosis and autophagic cell death (Todd, Lee, & Glimcher, 2008) , we therefore investigated whether celastrol could activate the ER stress response using the dual-luciferase reporter assays. Both celastrol and thapsigargin, a positive regulator for the elevation of cytosolic Ca
2+
, markedly increased the expression of ER stress markers ATF6, CHOP, GRP78, and GRP94 in RAFLS (Figure 5e ), indicating that celastrol may similarly induce apoptosis and autophagic cell death via Ca 2+ release and ER stress activation in RAFLS.
3.6 | Celastrol suppresses AIA in rats via mobilization of Ca
Although celastrol has exhibited anti-arthritic effect in vivo Venkatesha, Yu, Rajaiah, Tong, & Moudgil, 2011 ) through inhibition of cytokines, chemokines, and inflammatory mediators (Cascao, Fonseca, & Moita, 2017) , the role of celastrol-mediated Ca 2+ in RA therapy remains unclear. Therefore, the possible anti-arthritic effect (e) Activation of the ATF6, CHOP, GRP78, and GRP94 signalling in celastrol-treated RAFLS. ATF6-, CHOP-, GRP78-, and GRP94-containing dual-luciferase reporter plasmidtransfected RAFLS were treated with DMSO or 1-μM celastrol for 24 hr, and thapsigargin (TG, 1 μM) was used as a positive control. Cell lysates were harvested for dual-luciferase reporter assay. The data are expressed as the mean values ± SEM of five independent experiments. *P < .05, significantly different from DMSO-treated control or celastrol-treated group of celastrol via Ca 2+ mobilization was examined in the AIA rat model.
As shown in Figure 6a The celastrol-induced effects on autophagy activation and vimentin suppression were mitigated by co-treatment of celastrol and BAPTA/AM, which decreases intracellular Ca 2+ levels. Accordingly, the anti-arthritic effect of celastrol was partly attributable to the elevated Ca 2+ and its downstream activation of the autophagic pathway.
3.7 | The calcium-dependent/-binding proteins calmodulin, calpains, and calcineurin play critical roles in celastrol-mediated anti-arthritis effect in AIA rats
Celastrol mobilized cytosolic Ca 2+ in patient-derived RASFs and regulated 23 out of 370 genes associated with inflammation and autoimmunity (Dias et al., 2018) . Accordingly, expression of these Ca
-induced genes was validated using the joint tissues from our AIA model. Realtime PCR analysis indicated that except for CD40, GLMN, and TRAP1, the expression of the other 20 genes was almost significantly down-regulated in our AIA model treated with celastrol, whereas cotreatment with the Ca 2+ chelator, BAPTA/AM abolished the downregulation of genes mediated by celastrol (Figure 7 ). These results suggest the possible therapeutic role of Ca 2+ signalling in RA condition. Ca 2+ is a second messenger that is required for the signal transduction of many cellular processes (Clapham, 2007) , and calmodulin, calcineurin, and calpains are well-known downstream modulators of Ca 2+ -dependent enzymes, such as protein kinases, phosphatases, and proteases (Villalobo A, 2018) . Therefore, the role of celastrol-mediated Ca 2+ signalling in the regulation of inflammatory and autoimmunityassociated gene expression was verified by knockdown of these three Ca 2+ -binding/-dependent proteins. To ensure high efficiency in transfection and knockdown of genes, we used the RAFLS cells for validation of these 23 genes of interest by specific siRNA knockdown of calmodulin, calcineurin, and calpains individually, prior to celastrol treatment. In Figure S3 , effective knockdown of the target genes was achieved by transfecting the cocktail of siRNAs specific to different gene isoforms of calmodulin (CALM1 + CALM2 + CALM3), calpains (CAPN1 + CAPN2), and calcineurin (PPP3CA + PPP3CB + PPP3CC). ) after arthritis induction for 36 days. Hind paw volumes (ml) and arthritic scores were determined every 3 days. The data are expressed as the mean values ± SEM (n = 8). (d) The microCT scores of celastrol-treated AIA rats. MicroCT scores were obtained from five disease-related indexes of microCT analyses of the calcaneus -bone mineral density, bone volume fraction, cortical mineral density, trabecular number, and total porosity. The data are expressed as the mean values ± SEM from n = 8 rats per group. *P < .05, significantly different from vehicle-treated AIA group. # P < .05, significantly different from healthy control group. Δ P < .05 for microCT score comparison between celastrol treatment group and celastrol plus BAPTA/AM treatment group. (e) The autophagic effect and proliferative rate of synovial fibroblasts in synovium of AIA rat treated by celastrol. Synovium tissues isolated from five rats of each treatment group were section and immune-stained with antibodies against autophagic marker LC3B and synovial fibroblasts marker vimentin prior to secondary antibody (GOXMO TRITC HIGH XADS) treatment. The fluorescence images shown are the representative images from five independent animals. Bar charts show the ImageJ (RRID:SCR_003070) quantitation of the fluorescence signal from LC3B and vimentin. *P < .05, significantly different from vehicle-treated AIA group. For celastrol-treated AIA group # P < .05, significantly different from Cel + BM-treated AIA group FIGURE 7 Effect of BAPTA/AM in the expression of celastrol-regulated inflammatory and autoimmunity genes in the joint tissues of AIA rats. After the completion of drug treatment in the AIA rat model, the joint tissues harvested from the AIA vehicle control group (AIA Ctrl), celastrol 1 mg·kg −1 group (Cel), and celastrol 1 mg·kg −1 plus BAPTA/AM group (BM + Cel) were prepared for RNA isolation, reverse transcription into cDNA, and real-time qPCR analysis of 23 genes of interest related to inflammation and autoimmunity (Dias et al., 2018) . Among these 23 genes identified in the human RASF studies, 20 of their counterparts in rats have been identified as being down-regulated by celastrol-induced increase of calcium concentration in a similar pattern. After RT-qPCR, gene expression was normalized to GAPDH, relative to AIA vehicle control, and analysed using the 2 −ΔΔCT method. The data are presented as the mean ± SEM, *P < .05, significantly different from AIA or Cel + BM-treated group -dependent modulators in celastrol-mediated inflammatory and autoimmunity gene expression. RAFLS were treated with celastrol (Cel; 1 μM) with or without transfection of a mixture of siRNA for calmodulin genes (CALM1 + CALM2 + CALM3), calpain isoforms catalytic subunit genes (CAPN1 + CAPN2), or calcineurin isoforms catalytic subunit genes (PPP3CA + PPP3CB + PPP3CC) and compared to cells transfected with control siRNA. After RT-qPCR analysis of 22 genes associated with inflammation and autoimmunity, gene expressions were normalized to GAPDH, relative to control siRNA, and analysed using the 2 −ΔΔCT method. The data are the mean ± SEM from five independent experiments. *P < .05, significantly different from untreated or Cel + siRNA group Li et al., 2012; Nanjundaiah et al., 2012; Li et al., 2013; Astry et al., 2015; Jiang et al., 2015; Lv et al., 2015) . Although the molecular targets responsible for the celastrol-mediated antiarthritic effect have been identified (Cascao et al., 2012; Li et al., 2012; Li et al., 2013; Astry et al., 2015; Cascao, Fonseca, & Moita, 2017) , the mechanistic role of Ca 2+ signalling underpinning such therapeutic effects remains unclear. Emerging evidence suggests that Ca 2+ flux may be involved in the pathogenesis of RA. For example, significant differences in ER Ca 2+ concentrations were found in synovial fluid T cells from patients with chronic inflammatory arthritis after T cell receptor stimulation, when compared to normal T cells (Carruthers, Arrol, Bacon, & Young, 2000) . The activation of neutrophils isolated from RA patients was correlated to the Ca 2+ entry regulated by CD147-induced modifications of lipid rafts, which modulates the downstream activation of the cation channel TRPM7 (Wang et al., 2014) . Apart from cellular activation, Ca 2+ flux is associated with synovial accumulation of autoantigen in RA patients by triggering the activation of peptidylarginine deiminase and subsequent citrullination of vimentin in macrophages (Vossenaar et al., 2004) . In addition, conformational changes resulting in altered ATPase activity of SERCA1 have been reported in AIA rats which are correlated with the systemic inflammatory status of the animal model (Strosova et al., 2011 (Wang et al., 2016) . The blockade of store-operated Ca 2+ release-activated channels with the use of neutralizing antibodies can also effectively suppress the activity of T cells and B cells derived from RA patients (Liu et al., 2017) . Intriguingly, ionomycin-mediated Ca 2+ modulation enhanced the tensile properties of developing engineered articular cartilage (Natoli et al., 2010) .
In this study, we examined the potential of inhibiting RA progres- (Feng et al., 2013) , which is closely related to the phosphorylation status of the enzyme and may, in part, be regulated by heat shock protein 90 (Zhang et al., 2008) . In addition, celastrol can also target the proteasome to activate the pro-apoptotic unfolded protein response pathway and autophagy in cancer cells (Fribley et al., 2015; Wang et al., 2012) . Therefore, the multi-target nature of celastrol has aroused safety concerns. In fact, the actions of celastrol appeared to be more selectively expressed in the inflammatory RAFLS and cancer cells. It is possible that the ER stress of these cells is already at a high level, such that further stimulation after celastrol exposure, may exceed a critical level leading to induction of ER stress-associated cytotoxicity. On the contrary, in normal cells exhibiting basal (low) levels of ER stress, the administration of celastrol may only up-regulate the ER stress to the cytoprotective threshold of the pathway (rather than cytotoxic levels), which could partly explain the higher tolerance towards celastrol treatment. well as other signalling proteins, including membrane receptors, channels, and structural proteins (Villalobo A, 2018) . In chronic inflammatory arthritis, abnormal activation of calcineurin (a Ca
-calmodulin activated phosphatase) in synoviocytes was observed which could contribute to the corresponding pathogenesis (Yoo et al., 2006) .
Calpains, a set of Ca
-activated proteases, have also been shown to participate in cartilage destruction in collagen-induced arthritic knee joints of mice (Szomor, Shimizu, Fujimori, Yamamoto, & Yamamuro, 1995) . Therefore, we propose that celastrol-mediated Ca (Astry et al., 2015; Cascao et al., 2012; Han et al., 2015) and/or other molecular pathways such as IL-17A and NF-κB signalling Li et al., 2013) as mentioned previously independent of Ca 2+ signalling, which is supported by the observation that BAPTA/AM alone was unable to completely block the therapeutic effect of celastrol.
SERCA is a novel therapeutic target for cancer treatment, especially in multidrug-resistant tumours (Wong et al., 2013; Xu, Shao, & Zeng, 2013) . The current study indicates the potential therapeutic role of SERCA in refractory RA through eliminating apoptosis-and multidrug-resistant SLFs via calcium-induced autophagic cell death.
With the essential role of SERCA in maintaining normal cellular homeostasis, specific SERCA inhibitors such as thapsigargin are likely to result in significant toxicity to normal SLFs. This limitation has led to an increasing interest in the development of prodrug strategies to reduce the off-target-organ side effects and systemic toxicities (Yuan, Quan, et al., 2012) . For instance, methacrylamide copolymer-based dexamethasone prodrug, hydrogen peroxide-sensitive prodrugs of MTX, and aminopterin have been synthesized for the treatment of RA. While maintaining a comparable therapeutic efficacy, these prodrugs have resulted in a safer toxicity profile and an increased the therapeutic window, compared to their parent drugs (Peiro Cadahia et al., 2018; Yuan, Nelson, et al., 2012) . Therefore, it is worthwhile to further investigate whether the toxicity of celastrol can be minimized using similar prodrug strategies (Wang, Liu, Wang, He, & Chen, 2011) to provide a safer agent for treating RA patients who are less responsive to current anti-arthritic agents.
| CONCLUSION
This study has provided new insights into how celastrol regulates a panel of inflammatory and autoimmunity-associated genes via activation of Ca
2+
-binding/-dependent proteins. Through interlinking the possible genes regulating apoptosis, proliferation, inflammation, immunity, angiogenesis, and migration/invasion process of AIA models after treatment with celastrol, the current investigation has revealed the detailed molecular mechanisms of celastrol in the effective treatment of RA via calcium signalling.
